45 Wadhurst Drive
Boronia, VIC 3155
Australia
61 3 9801 8888
https://en.idtaus.com.au
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Paul Anthony McDonald | Chief Executive Officer | 370,53k | N/A | N/A |
Mr. Vasanthakumar Mahendran | Chief Financial Officer | 239,44k | N/A | N/A |
Mr. Jim Sosic | COO & Operations Director | 18,7k | N/A | N/A |
Ms. Priscilla Thiyageas | Quality Director | 252,78k | N/A | N/A |
Ms. Paula Coutts | Head of People & Safety | N/A | N/A | N/A |
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP | Company Secretary | N/A | N/A | 1964 |
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, chemistry and microbiology quality control laboratory, and quality assurance services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
IDT Australia Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.